| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |